PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel study charts aggressive prostate cancer

Study in the Journal Cell Cycle reveals new developments in prognosis

2013-11-18
(Press-News.org) Contact information: Cara Lasala
cara.lasala@cshs.org
310-423-7798
Cedars-Sinai Medical Center
Novel study charts aggressive prostate cancer Study in the Journal Cell Cycle reveals new developments in prognosis LOS ANGELES (Nov. 18, 2013) – Many patients diagnosed with prostate cancer have indolent, slow-growing forms of the disease that are not life-threatening. However, more than 30,000 American men will die from aggressive prostate cancer this year alone. This sharp contrast between low-risk and aggressive disease presents a challenge for many researchers and physicians as they diagnose patients and also determine the prognosis of the men with the most aggressive forms of prostate cancer.

Investigators in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute have made extensive progress in understanding the molecular mechanisms of disease progression. These results may help scientists better understand the prognosis of patients diagnosed with advanced prostate cancer. The study, published in the journal Cell Cycle and led by Dolores Di Vizio, MD, PhD, may ultimately lead to the development of new biomarkers for not only prognosis, but also a patient's potential response to therapy.

"One of the long-standing difficulties in treating men with advanced prostate cancer has been predicting the response to given therapies or treatments," said Di Vizio, associate professor in the Department of Surgery, Department of Pathology and Laboratory Medicine and Department of Biomedical Sciences. "These latest research findings provide tangible insight into the molecular and structural phenomena that result in prostate cancer metastases. They have the potential to create a new source of biomarkers and an innovative standard of care. These findings may also help distinguish individualized treatment plans best suited for each patient."

The new source of biomarkers is large oncosomes, which are vesicles released from aggressive prostate cancer cells with highly migratory features. These large oncosomes carry tumor molecules and have been shown in previous studies to contribute to tumor progression. This study demonstrates, for the first time in human samples, that identification of circulating large oncosomes can be an indicator of patients with more aggressive, treatment-resistant disease. Also notable, researchers found that large oncosomes contain microRNA, a molecule that regulates several biological processes now proven to influence tumor progression.

At the Cedars-Sinai Urologic Oncology Program, researchers and physicians work in close collaboration to discover personalized options for patients with indolent prostate disease to those with aggressive cancer. This latest study will amplify the genetic and molecular understanding of aggressive prostate cancer.

"Many of the latest research developments and treatments for urologic cancers have been initiated from Cedars-Sinai investigators and physicians," said Robert Figlin, MD, FACP, associate director of the Samuel Oschin Comprehensive Cancer Institute, professor of Medicine and Biomedical Sciences and the Steven Spielberg Family Chair in Hematology Oncology. "These latest research observations may identify novel ways to measure a patient's prognosis and are just a stepping stone for the many discoveries moving down the pipeline in our cancer institute."

### Cedars-Sinai collaborators include Michael Freeman, PhD, director of Cancer Biology and Therapeutics and vice chair of Research and Surgery in the department of Biomedical Sciences; Leland Chung, PhD, director of the Urologic Oncology Research Program and professor in the Department of Medicine; Edwin Posadas, MD, FACP, co-medical director in the Urologic Oncology Program and assistant professor in the Department of Medicine; Hyung Lae Kim, MD, director of Academic Programs in the Division of Urology and co-medical director of the Urologic Oncology Program; Neil Bhowmick, PhD, research scientist and associate professor in the Department of Medicine; and fellows Matteo Morello, PhD, Valentina Minciacchi, and Julie Yang.

Francesca Demichelis, PhD, from Centro for Integrative Biology at the University of Trento, as well as researchers from Istituto Nazionale di Genetica Molecolare and Istituto Nazionale Tumori in Milan and NanoSight Inc. contributed to the study.

The research was supported by the National Cancer Institute (CA131472 [R00] to DDV, R01CA143777 to MRF) and the Steven Spielberg Discovery Fund in Prostate Cancer Research.

Citation: Cell Cycle. 2013 Nov 15


ELSE PRESS RELEASES FROM THIS DATE:

New research finds link between red cell distribution width levels and depression in heart patients

2013-11-18
New research finds link between red cell distribution width levels and depression in heart patients DALLAS – Researchers at the Intermountain Medical Center Heart Institute have discovered a link between elevated red cell distribution width levels and ...

Long-term oral contraceptive users are twice as likely to have serious eye disease

2013-11-18
Long-term oral contraceptive users are twice as likely to have serious eye disease Research shows birth control use over three years could be a risk factor for glaucoma NEW ORLEANS – Nov. 18, 2013 – Research presented today, at the 117th Annual Meeting of the American ...

Faster surgery may be better for hip fractures: McMaster study

2013-11-18
Faster surgery may be better for hip fractures: McMaster study In many countries waits for hip surgery can be 24 hours or longer Hamilton, Nov. 18, 2013 – The speed of surgery after a hip fracture may have a significant impact on outcomes for older patients, ...

Program helps at-risk family members of patients with heart disease improve their own heart health

2013-11-18
Program helps at-risk family members of patients with heart disease improve their own heart health Randomized clinical trial Family members of patients with heart disease adopted healthier lifestyles and decreased their risk of a cardiovascular ...

Early surgery for hip fractures in older adults may improve outcomes

2013-11-18
Early surgery for hip fractures in older adults may improve outcomes Randomized controlled trial Early surgery for hip fractures in older people may substantially improve outcomes for patients, according to the results from a randomized controlled ...

Blood growth factor boosts effect of exercise in peripheral artery disease

2013-11-18
Blood growth factor boosts effect of exercise in peripheral artery disease A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown. The results are scheduled for ...

Greater density of coronary artery calcium associated with lower risk of CHD, CVD

2013-11-18
Greater density of coronary artery calcium associated with lower risk of CHD, CVD Chicago – Michael H. Criqui, M.D., M.P.H., of the University of California, San Diego, and colleagues determined the independent associations of coronary artery calcium (CAC) volume and ...

Type of cell therapy does not improve walking ability for patients with peripheral artery disease

2013-11-18
Type of cell therapy does not improve walking ability for patients with peripheral artery disease Chicago – Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage ...

Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy

2013-11-18
Therapy using stem cells, bone marrow cells, appears safe for patients with ischemic cardiomyopathy Chicago – Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial ...

Addition of certain drugs to diuretic therapy does not improve kidney function

2013-11-18
Addition of certain drugs to diuretic therapy does not improve kidney function Chicago – Horng H. Chen, M.B.B.Ch., of the Mayo Clinic, Rochester, Minn., and colleagues conducted a randomized trial to determine whether, as compared with placebo, the addition of ...

LAST 30 PRESS RELEASES:

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

State gun laws and firearm-related homicides and suicides

Use of tobacco and cannabis following state-level cannabis legalization

Long-term obesity and biological aging in young adults

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

Adults with autism show similar brain mapping of body parts as typically developing adults

Uncovering behavioral clues to childhood maltreatment

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

[Press-News.org] Novel study charts aggressive prostate cancer
Study in the Journal Cell Cycle reveals new developments in prognosis